Study guide
11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
BONENT Certified Hemodialysis Nurse CHN
Track your progress as you read
Finished sections get a check mark.
1 Exam Orientation
1.1 Current CHN Exam Facts and Study Strategy
2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology
2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD
3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations
3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management
4 Individualized Nursing Care
4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral
5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR
6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters
6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention
7 Chapter 5: Cannulation Practice & Access Complications
7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management
8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring
8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment
9 Equipment and Laboratory Skills
9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results
10 Chapter 7: Acute Intradialytic Complications & Emergencies
10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss
11 Extended and Acute Treatment
11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
12 Chapter 8: Nephrology Pharmacology in Hemodialysis
12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing
13 Home and Peritoneal Dialysis
13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care
14 Kidney Transplantation
14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes
15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing
15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety
16 Clinical Unit Management
16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care
17 Chapter 10: Supervision, Administration & Professional Practice
17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care
18 Professional Development
18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation
19 Environmental Hazards and Emergency Planning
19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions
11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
Key Takeaways Explain This Topic AI
AKI treatment decisions use symptoms, trends and clinical context rather than one BUN threshold.
Hemodynamic instability and neurologic risk influence modality and initial clearance rate.
Track urine output and recovery; dialysis dependence in AKI does not automatically establish permanent kidney failure.
Last updated: October 2026
Why Acute Care Differs
A patient with acute kidney injury (AKI) may need dialysis because of refractory hyperkalemia, pulmonary edema, acidosis, symptomatic uremia or a selected poisoning. The underlying problem may be reversible. This differs from assuming permanent nephron loss in established maintenance treatment. The nurse tracks renal recovery and changing needs while responding to the acute illness that caused the injury.
Review recent creatinine, urine output, hemodynamics, medication exposure, fluid balance and imaging or obstruction findings. AKI can occur on top of CKD. A prior stable outpatient creatinine and a documented baseline help interpret the current change. Anuria requires prompt evaluation, but it does not identify the cause by itself. Correcting obstruction, sepsis, bleeding or a nephrotoxic exposure may change the course even while dialysis supports the patient.
Preparation and Prescription Verification
Confirm the indication, modality, access permission, duration, blood and dialysate flows, bath, fluid goal, anticoagulation and laboratory schedule. A standard outpatient four-hour prescription may be inappropriate for a first dialysis in marked azotemia or a patient needing vasopressors. Discuss instability and neurologic risk with the nephrologist rather than independently lowering or increasing efficiency.
Urgent access is commonly a nontunneled catheter, but the inserting team chooses the site and confirms position and readiness. Check catheter integrity, secure connections and use aseptic technique. Avoid assuming the catheter can be used solely because it is visible. Review recent surgery, active bleeding, thrombocytopenia and exposure to heparin before implementing the anticoagulation plan.
Modality and Hemodynamic Risk
Intermittent HD clears solutes rapidly, while continuous kidney replacement therapy provides slower ongoing fluid and solute control. Prolonged intermittent techniques occupy an intermediate practical role. The team considers circulation, neurologic status, toxin urgency, resources and expertise. Continuous treatment is not automatically superior for every patient, and intermittent treatment is not automatically safe because a machine is available.
In severe hemodynamic instability, fast removal may worsen organ perfusion. A patient can be edematous and have poor effective arterial volume. The fluid goal depends on the actual assessment and overall resuscitation plan. Monitor pressure, pulse, consciousness, respiratory state and the response to each intervention. New instability requires immediate evaluation for the cause, including sepsis, bleeding, arrhythmia or a treatment reaction.
Protect Against Rapid Osmotic Change
Marked azotemia, first dialysis, resumed treatment after prolonged absence and neurologic vulnerability raise concern about dialysis disequilibrium. The clinician may prescribe lower initial efficiency, shorter initial treatment, staged sessions or another modality. Membrane flux alone does not define urea efficiency. Do not infer that a high-flux membrane is categorically forbidden or that simply reducing the blood flow makes every prescription safe.
New headache, vomiting, confusion or seizures requires urgent assessment. Check for hypoglycemia, stroke, electrolyte abnormalities and other emergencies as well as disequilibrium. A diagnostic label should not delay stopping unsafe exposure or protecting the airway. The nurse follows emergency orders for severe neurologic symptoms; hypertonic agents are not given merely because a patient reports an ordinary headache.
Dynamic Medication and Electrolyte Needs
AKI changes medication clearance, but recovery may change it again. Ask pharmacy and the prescriber to review antibiotics, sedatives, anticoagulants and nephrotoxic agents. Drug dosing depends on the actual modality and delivered treatment, not just 'on dialysis.' Interruptions in continuous therapy can substantially change clearance and should be communicated.
Potassium and phosphate may fall during repeated or continuous therapy, sometimes requiring ordered replacement. A low-potassium bath copied from the first emergency can become inappropriate after stabilization. Monitor laboratory trends and specimen timing. Include nutrition, transfusions and all infusions in fluid accounting. Critically ill patients may receive substantial volume outside the dialysis circuit, so a machine UF total alone does not describe net daily balance.
Recovery and Continuity
Record urine output accurately and distinguish spontaneous output from output influenced by diuretics. A rise in urine volume suggests possible recovery but does not prove adequate solute clearance. The nephrologist evaluates kidney function and whether treatment can be reduced or stopped. Nurses do not omit a scheduled session based on one improved creatinine or extend permanent-access planning to every acute patient without review.
At transfer from hospital to outpatient care, identify that the patient has AKI, the suspected cause, current recovery assessment, access plan, prescription, medications and monitoring schedule. Avoid relabeling the patient as irreversible ESKD for convenience. Communicate recent instability and specify the responsible clinician for pending results. An AKI patient may require frequent changes that a stable maintenance workflow would miss.
Worked Priority Example
A septic patient with edema, potassium 6.4 mEq/L, increasing oxygen needs and low BP is referred for kidney replacement therapy. Priorities include stabilization, emergency potassium measures under orders, a carefully chosen modality and a fluid goal that accounts for perfusion. Simply maximizing UFR to reach an old target weight would be unsafe. The treatment supports the acute illness while the team continues infection control, hemodynamic care and recovery assessment.
Source: KDIGO AKI guideline .
Acute-Treatment Checks
Confirm the indication, current prescription and access readiness.
Review perfusion, bleeding and neurologic risk before initiation.
Track delivered treatment, fluid balance and changing electrolytes.
Communicate urine-output trends and the team’s recovery assessment.